LA HB920

Caps patient cost-sharing for GLP-1 medications at $200 per 30-day prescription for health coverage plans, regardless of the amount or type of medication needed

Requires coverage of GLP-1 medications regardless of the patient's specific medical condition or diagnosis, removing restrictions that limit coverage to only diabetes or specific conditions

Extends GLP-1 medication coverage requirements to Louisiana Medicaid, Office of Group Benefits (OGB), and other health plans

Authorizes the Louisiana Department of Health to seek federal Medicaid waivers and state plan amendments necessary to implement the coverage requirements

Defines GLP-1 (Glucagon-Like Peptide-1) medications as drugs that control blood sugar, digestion, and appetite, available in injectable or oral form